Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1446194 BALA CYNWYD, PA

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$549,113
+$142,402 QoQ
Shares Held
43,034
+45.5% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 103 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Derivatives in TNXP

reported options exposure · as of Jun 30, 2026
CallValue
$520,608
CallShares
40,800
PutValue
$1,864,236
PutShares
146,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. TNXP ranks #158 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNXP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $549,113 43,034
2026-06-30 $520,608 40,800
2026-06-30 $1,864,236 146,100
2026-03-31 $732,875 53,300
2026-03-31 $1,032,625 75,100
2026-03-31 $406,711 29,579
2025-12-31 $463,320 29,662
2025-12-31 $365,508 23,400
2025-12-31 $551,386 35,300
2025-09-30 $343,072 14,200
2025-09-30 $521,856 21,600
2025-09-30 $211,400 8,750
2025-06-30 $324,107 9,008
2022-03-31 $5,898 25,644
2021-12-31 $45,386 126,077
2021-03-31 $1,011,732 790,417
2020-06-30 $13,374 21,925
2020-03-31 $7,416 10,446